Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SUDARSHAN.BOthis companySudarshan Pharma Industries Ltd.	₹33.50	26.19×	3.9×	0.87×	14.89×	-232.9%	11.9%	6.8%	3.3%	14.9%	8.2%	-11.7%	1.82×	4.73×	1.85×	1.07×	0.0%	4	2.53	2	C+
ANUHPHR.NSAnuh Pharma Limited	₹82.78	16.37×	1.91×	0.87×	10.04×	12.6%	17.4%	6.5%	5.3%	11.7%	10.8%	-1.6%	0×	-0.12×	106.58×	2.22×	2.2%	—	—	2	C
BAFNAPH.NSBafna Pharmaceuticals Limited	₹472.80	23.31×	2.69×	1.72×	14.21×	-102.8%	13.4%	6.6%	7.4%	11.5%	7.2%	-5.1%	0.39×	1.71×	2.7×	1.57×	0.0%	5	—	1	C-
FREDUN.BOFredun Pharmaceuticals Limited	₹1,518.80	25.02×	2.94×	1.29×	10.87×	-205.7%	26.6%	13.1%	5.2%	11.7%	10.9%	0.5%	0.87×	1.94×	2.12×	1.68×	0.0%	3	—	2	C
JENBURPH.BOJenburkt Pharmaceuticals Limited	₹959.75	12.14×	2.14×	2.5×	8.36×	76.8%	49.4%	24.1%	20.6%	17.6%	14.9%	3.9%	0.01×	-0.06×	87.95×	4.11×	1.9%	2	—	3	B
PANCHSHEEL.BOPanchsheel Organics Limited	₹106.71	10.97×	0.84×	1.11×	7.08×	26.9%	21.8%	10.5%	10.1%	7.7%	5.5%	4.9%	0.04×	0.11×	45.96×	3.4×	3.5%	3	—	3	B
Peer median	—	16.37×	2.14×	1.29×	10.04×	12.6%	21.8%	10.5%	7.4%	11.7%	10.8%	0.5%	0.04×	0.11×	45.96×	2.22×	1.9%	3	—	2	—